Global High Content Screening / Imaging Market (2021-2026)

DUBLIN, September 3, 2021 / PRNewswire / – The report “High Content Screening / Imaging: Technologies and Global Markets 2021-2026” has been added to ResearchAndMarkets.com offer.

The global high content screening / imaging technologies market is expected to grow from $ 1.2 billion in 2021 to $ 2.3 billion by 2026 with a compound annual growth rate (CAGR) of 13.5% for the period 2021-2026.

The North American market for high-content screening / imaging technology is expected to grow from $ 448.2 million in 2021 to $ 744.1 million by 2026 with a compound annual growth rate (CAGR) of 10.7% for the period 2021-2026.

The European market for high content screening / imaging technology is expected to grow from $ 336.8 million in 2021 to $ 674.5 million by 2026 with a compound annual growth rate (CAGR) of 14.9% for the period 2021-2026

The current report offers a detailed picture of the High Content Screening / Imaging Market.

This report highlights the current and future potential of the High Content Filtering / Imaging market and provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities and market trends. The report also covers the market projections till 2026, along with the major market players.

This report discusses the High Content Filtering / Imaging industry and its various resources. It covers the entire high content screening / imaging market, including instrument or platform, consumables (reagents and kits), software and assays, and services. The report further analyzes the market based on application, providing analysis of drug discovery, oncology, compound profiling, molecular diagnostics, toxicity studies, and neuroscience. A comprehensive regional analysis of the market is also studied in the report.

The report includes

• 44 data tables and 28 supplementary tables
• An overview of global markets and technologies for high content screening / imaging
• Market size estimation and market trend analyzes, with data for 2019, 2020, estimates for 2021 and projection of CAGR to 2026
• Quantification of the High Content Screening / Imaging market based on component, end user, application, and region, and analysis of market drivers, restraints, and other forces impacting the market global
• Highlights of current and future market potential, detailed analysis of the regulatory framework and policies and information on new technologies and innovations in the industry
• Discussion on the advantages of high-throughput screening over manual screening and the impact of COVID-19 on MedTech and medical tourism
• Coverage of recent developments, research and development (R&D) exploration, clinical trials, and government programs to predict HCS / I market trends
• Analysis of market shares of key companies in the sector and coverage of events such as mergers and acquisitions, joint ventures, collaborations or partnerships, and other key market strategies and relevant patent analysis
• Company profiles of key players including Molecular Devices (Danaher), Thermo Fisher Scientific, Becton, Dickinson and Co., PerkinElmer Inc., Genedata AG and Yokogawa Electric Corp.

The major factor contributing to the growth of the HCS / I market is the increasing adoption of high content screening / imaging technology in research and development activities. The rapid adoption of HCS / Technology in the pharmaceutical industry and academic research centers indicates the importance of this information rich screening tool. Imaging of cell function has become increasingly important in understanding the underlying functional biology associated with new therapeutic targets.

The demand for improved technologies for cell research, government support and the emergence of sophisticated computer solutions, along with the growing demand for better screening systems, are increasing the demand for high content imaging in fully automated screening laboratories. . Furthermore, advancements and technological developments in biological research and discovery of more effective therapies for the treatment of human diseases are fueling the market growth. HCS / I systems have continuously evolved with many improvements to meet user demands for greater flexibility and the increasing demands of assays involving complex cell disease models. The increase in global drug research and development, increased investment, and the introduction of advanced imaging instruments are the other drivers of the HCS / I market. The high cost of HCS / I instrumentation is the main factor limiting the growth of the market.

The price of machinery and instrumentation prohibits a small economy country or research organization from purchasing HCS / I equipment. Companies are introducing more sensitive cameras and better light sources, such as LEDs and multi-color lighting, which increase the efficiency and reliability of the system and, therefore, the overall cost of microscopes. The price of HCS / I equipment ranges from one hundred thousand to one million dollars, depending on specifications. Inadequate infrastructure and less funding for R&D in emerging countries will also hamper the market as installation and maintenance costs are also very high and difficult to achieve for emerging economies. The adoption of HCS / I in the analysis of 3D spheroids, microtissues and phenotypic assays is expected to impact CRISPR-Cas9-based gene editing studies in the future. In addition, the increasing availability of perturbagens libraries and HCS / I infrastructure within academic research centers has generated widespread interest in HCS / I applications among academic researchers. The combination of HCS / I with chemical genetics, where small organic molecules are used to study biological systems, has emerged as a powerful approach to define protein functions and dissect signaling pathways. The rapid growth of genome-wide RNA interference (RNAi) technology for probing gene function in mammalian cell culture has systematically popularized HCS / I systems in academic research environments.

Main topics covered:

Chapter 1 Introduction

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

• Overview
• Scanning probe microscopy
• Scanning electron microscopy
• Transmission electron microscopy
• Technological advances
• Cytometers
• Detectors / Sensors
• Liquid handling instruments
• Process overview
• High content screening (HCS)
• High Throughput Screening (HTS)

Chapter 4 Impact of the COVID-19 pandemic

• introduction
• Impact on MedTech
• Elective and non-critical procedures
• Change in manufacturing
• Regulatory delays, clinical trials and product launches
• Supply chain disruptions
• Medical tourism

Chapter 5 Market Dynamics

• Market factors
• Increase in R&D budget
• Advantages over manual and high throughput screening
• Technological Advances in High Content Screening / Imaging
• Market constraints
• Expensive equipment
• Inadequate infrastructure and funding for R&D in emerging countries
• Market opportunities
• Opportunities in various 3D applications
• Emerging economies

Chapter 6 Market Breakdown by Component

• Instruments and platforms
• Imaging devices
• Cytometers
• Plate readers
• Light sources
• Detectors / Sensors
• Liquid handling instruments
• Market size and forecast
• Consumables (Reagents and Kits)
• Market size and forecast
• Software and Analytics
• Warehouse Image and Database Management Software by Thermo Fisher Scientific
• OpenHiCAMM software (Open Hi Content Acquisition for? Manager)
• Market size and forecast
• Services
• SiARN screens
• Fluorescent Cellular Assay Analysis
• Robotic handling of liquids and microplates
• Market size and forecast

Chapter 7 Market Split by Application

• Global High Content Screening / Imaging Market By Application
• Drug discovery
• Oncology
• Compound profiling
• Molecular diagnostics
• Toxicity studies
• Neuroscience

Chapter 8 Market Breakdown by End User

• Global High Content Screening / Imaging Market By End User
• Companies
• Academics
• Laboratories and pathology centers

Chapter 9 Market Breakdown by Region

• Global High Content Screening / Imaging Market By Region
• North America
• Europe
• Asia Pacific
• Rest of the world (RoW)

Chapter 10 Patent Examination

• introduction
• Patents granted by year of publication, 2015-2017

Chapter 11 Competitive Landscape

• Overview
• Analysis by the company
• Strategies
• Regional distributors
• End users
• Recent developments

Chapter 12 Instrument Price Analysis by Major Players

• Thermo Fisher Scientific
• Molecular devices (Danaher)
• Yokogawa Electric Corp.
• BioTek (Agilent)
• Essen Bioscience (Sartorius)
• Biosystems Logos
• Other major players

Chapter 13 Company Profiles

• Albany Molecular Research Inc. (Amri)
• Aurélia Bioscience Ltée.
• Axxam Spa
• Becton, Dickinson et Cie.
• Biotek Instruments Inc.
• Charles River
• Corning Inc.
• Creative biolabs
• Curiox Biosystems Inc.
• Cytoo Sa
• Danaher Corp.
• De Novo Software
• Discoverx Corp.
• Essen Biosciences
• Fluxion Biosciences
• Genedata Ag
• Hudson Robotics Inc.
• Instrument systems
• Lumencor inc.
• Merck Millipore
• Olympus Corp.
• Perkinelmer inc.
• Phenovista Biosciences SARL
• Platypus Technologies
• Groupe Tecan Ltée.
• Thermo Fisher Scientific Inc.
• Thorlabs Inc.
• Vala Sciences inc.
• Yokogawa Electric Corp.

For more information on this report, visit https://www.researchandmarkets.com/r/xwru5d

Media contact:
Research and markets
Laura Wood, senior
[email protected]

For EST office hours, call + 1-917-300-0470
For USA / CAN call toll free + 1-800-526-8630
For GMT office hours, call + 353-1-416-8900

US Fax: 646-607-1904
Fax (outside the United States): + 353-1-481-1716

SOURCE Research and Markets

Related links

http://www.researchandmarkets.com